We are live on ! Find out more
Mirae Asset Global ETFs Holdings

Mirae Asset Global ETFs Holdings Portfolio holdings

AUM $73.7B
1-Year Est. Return 53.56%
This Fund
S&P 500
This Quarter Est. Return
+7.31%
1 Year Est. Return
+53.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$44.5B
AUM Growth
+$2.4B
Cap. Flow
+$44.6M
Cap. Flow %
0.1%
Top 10 Hldgs %
21.94%
Holding
3,262
New
258
Increased
1,895
Reduced
901
Closed
195

Sector Composition

Rank Sector Weight
1 Technology 26.35%
2 Industrials 18.87%
3 Energy 12.66%
4 Materials 9.31%
5 Consumer Discretionary 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XFOR icon
2876
X4 Pharmaceuticals
XFOR
$425M
$61.8K ﹤0.01%
3,076
+961
+45% +$20.1K
RGTI icon
2877
Rigetti Computing
RGTI
$6.21B
$61.5K ﹤0.01%
+78,552
New +$71.7K
STXS icon
2878
Stereotaxis
STXS
$137M
$61.4K ﹤0.01%
+30,077
New +$60.5K
PEBK icon
2879
Peoples Bancorp of North Carolina
PEBK
$237M
$61.1K ﹤0.01%
+2,407
New +$69.3K
LVWR icon
2880
LiveWire
LVWR
$256M
$60.7K ﹤0.01%
9,958
+196
+2% +$1.34K
TE
2881
T1 Energy
TE
$1.41B
$60.4K ﹤0.01%
+62,254
New +$85K
PAMT
2882
PAMT Corp
PAMT
$285M
$60.4K ﹤0.01%
3,264
+10
+0.3% +$182
ASPI icon
2883
ASP Isotopes
ASPI
$539M
$60.2K ﹤0.01%
+21,654
New +$57.6K
SMLR
2884
DELISTED
Semler Scientific
SMLR
$60.1K ﹤0.01%
2,554
+927
+57% +$26.6K
AGEN
2885
Agenus
AGEN
$315M
$59.9K ﹤0.01%
10,931
+1,169
+12% +$8.75K
KWY
2886
Kingsway Corp
KWY
$283M
$59.4K ﹤0.01%
7,176
+668
+10% +$5.42K
CTNM
2887
Contineum Therapeutics
CTNM
$576M
$58.9K ﹤0.01%
+3,077
New +$59K
CVGI icon
2888
Commercial Vehicle Group
CVGI
$130M
$58.8K ﹤0.01%
18,107
+1,837
+11% +$7.48K
SKIN icon
2889
SkinHealth Systems
SKIN
$85.9M
$58.7K ﹤0.01%
40,746
+71
+0.2% +$116
TNYA icon
2890
Tenaya Therapeutics
TNYA
$164M
$58.5K ﹤0.01%
30,292
+7,514
+33% +$21.2K
CRDF icon
2891
Cardiff Oncology
CRDF
$76.6M
$58.3K ﹤0.01%
+21,834
New +$51.6K
QUIK icon
2892
QuickLogic
QUIK
$230M
$58K ﹤0.01%
+7,564
New +$69.7K
PBYI icon
2893
Puma Biotechnology
PBYI
$450M
$57.9K ﹤0.01%
+22,710
New +$68.7K
LFCR icon
2894
Lifecore Biomedical
LFCR
$179M
$57.6K ﹤0.01%
+11,690
New +$61.1K
RILY icon
2895
BRC Group Holdings
RILY
$303M
$57.4K ﹤0.01%
10,931
+1,169
+12% +$13K
ABOS icon
2896
Acumen Pharmaceuticals
ABOS
$184M
$57.1K ﹤0.01%
+23,015
New +$62.4K
EGAN icon
2897
eGain
EGAN
$206M
$56K ﹤0.01%
10,978
+1,216
+12% +$7.8K
VERU icon
2898
Veru
VERU
$46M
$55.7K ﹤0.01%
+7,248
New +$62.5K
RGLS
2899
DELISTED
Regulus Therapeutics
RGLS
$55.2K ﹤0.01%
+35,154
New +$58.2K
MORN icon
2900
Morningstar
MORN
$7.76B
$54.9K ﹤0.01%
173
-54
-24% -$16.8K

Similar funds

Mirae Asset Global ETFs Holdings's Q3 2024 Portfolio in Review

As of Q3 2024, Mirae Asset Global ETFs Holdings held 3,262 positions worth $44.5B, up 5.7% from $42.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Mirae Asset Global ETFs Holdings's Q3 2024 filing shows 258 new, 1,895 increased, 901 reduced and 195 closed positions. Its largest new stake was SPDR Gold MiniShares Trust: 1,015,493 shares worth $52.9M. The largest sale was Vanguard Russell 2000 ETF, an estimated $229M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Industrials and Energy.

  • Mirae Asset Global ETFs Holdings's largest Q3 2024 buy was SPDR Gold MiniShares Trust: 1,015,493 shares worth $52.9M.
  • Mirae Asset Global ETFs Holdings added most to Global X Russell 2000 ETF in Q3 2024, an estimated $144M increase.
  • Mirae Asset Global ETFs Holdings's biggest Q3 2024 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $139M.
  • Mirae Asset Global ETFs Holdings fully exited Vanguard Russell 2000 ETF in Q3 2024, selling an estimated $229M.
  • Mirae Asset Global ETFs Holdings's ten largest holdings make up 22% of its $44.5B portfolio in Q3 2024.
  • Mirae Asset Global ETFs Holdings opened 258 new positions and closed 195 in Q3 2024.
  • Mirae Asset Global ETFs Holdings's portfolio value rose 5.7% quarter-over-quarter to $44.5B.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.